The Covid-19 Vaccine Production Club

dc.creatorEvenett, Simon J.
dc.creatorHoekman, Bernard
dc.creatorRocha, Nadia
dc.creatorRuta, Michele
dc.date2021-03-11T14:20:07Z
dc.date2021-03-11T14:20:07Z
dc.date2021-03
dc.date.accessioned2026-07-01T00:37:17Z
dc.descriptionIn the first two months of 2021, the production of COVID-19 vaccines has suffered setbacks delaying the implementation of national inoculation strategies. These delays have revealed the concentration of vaccine manufacture in a small club of producer nations, which in turn has implications for the degree to which cross-border value chains can deter more aggressive forms of Vaccine Nationalism, such as export curbs. This paper documents the existence of this club, taking account of not just the production of final vaccines but also the ingredients of and items needed to manufacture and distribute COVID-19 vaccines. During 2017–19, vaccine producing nations sourced 88 percent of their key vaccine ingredients from other vaccine producing trading partners. Combined with the growing number of mutations of COVID-19 and the realization that this coronavirus is likely to become a permanent endemic global health threat, this finding calls for a rethink of the policy calculus towards ramping up the production and distribution of COVID-19 vaccines, its ingredients, and the various items needed to deliver them. The more approved vaccines that are safely produced, the smaller will be the temptation to succumb to zero-sum Vaccine Nationalism.
dc.formatapplication/pdf
dc.formattext/plain
dc.identifierhttp://documents.worldbank.org/curated/en/244291614991534306/The-Covid-19-Vaccine-Production-Club-Will-Value-Chains-Temper-Nationalism
dc.identifierhttps://hdl.handle.net/10986/35244
dc.identifier10.1596/1813-9450-9565
dc.identifier.urihttp://hdl.handle.net/123456789/407550
dc.languageEnglish
dc.publisherWorld Bank, Washington, DC
dc.relationPolicy Research Working Paper;No. 9565
dc.rightsCC BY 3.0 IGO
dc.rightshttp://creativecommons.org/licenses/by/3.0/igo
dc.rightsWorld Bank
dc.subjectCORONAVIRUS
dc.subjectCOVID-19 VACCINATION
dc.subjectVALUE CHAIN
dc.subjectVACCINE NATIONALISM
dc.subjectEXPORT CONTROL
dc.subjectEXPORT BAN
dc.subjectmRNA
dc.subjectLIPIDS
dc.subjectNITRILE GLOVE
dc.subjectSYRINGE
dc.subjectVIAL
dc.subjectVACCINE PRODUCTION
dc.titleThe Covid-19 Vaccine Production Club
dc.titleWill Value Chains Temper Nationalism?
dc.typeWorking Paper
dc.typeDocument de travail
dc.typeDocumento de trabajo

Archivos

Colecciones